Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lipodystrophy Syndrome, HIV”

98 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 98 results

Large-scale testing (Phase 3)Study completedNCT01077765
What this trial is testing

Polyacrylamide Hydrogel Injection in HIV-related Lipoatrophy

Who this might be right for
HIV InfectionAntiretroviral Side EffectsLipodystrophy Syndrome Related to HIV Infection
Assistance Publique - Hôpitaux de Paris 100
Post-approval studies (Phase 4)UnknownNCT00426296
What this trial is testing

SHARE: Simple HAART With Abacavir, Reyataz, and Epivir

Who this might be right for
HIV InfectionsLipodystrophy
Clinical Alliance for Research & Education - Infectious Diseases, LLC.
Large-scale testing (Phase 3)Study completedNCT00383734
What this trial is testing

Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE

Who this might be right for
HIV-Associated Lipodystrophy Syndrome
French National Agency for Research on AIDS and Viral Hepatitis 148
Post-approval studies (Phase 4)Study completedNCT00006190
What this trial is testing

Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop Lipodystrophy

Who this might be right for
HIV InfectionsLipodystrophy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Testing effectiveness (Phase 2)Study completedNCT00367744
What this trial is testing

Rosiglitazone Effect on Mitochondria and Lipoatrophy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 71
Not applicableStudy completedNCT05383456
What this trial is testing

The Visceral Adiposity Measurement and Observation Study

Who this might be right for
HIVHIV-InfectionsHIV-1-infection+16 more
Theratechnologies 196
Testing effectiveness (Phase 2)Study completedNCT00656175
What this trial is testing

Raltegravir Therapy for Women With HIV and Fat Accumulation

Who this might be right for
HIV InfectionsLipodystrophy
University of California, Los Angeles 39
Not applicableLooking for participantsNCT03087253
What this trial is testing

The LD Lync Study - Natural History Study of Lipodystrophy Syndromes

Who this might be right for
Lipodystrophy (Genetic or Acquired, Non HIV)
University of Michigan 500
Not applicableStudy completedNCT00433992
What this trial is testing

Metabolic Effects of Non-Thymidine Analogue Anti-HIV Medications

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 56
Not applicableStudy completedNCT00106795
What this trial is testing

Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS

Who this might be right for
HIV InfectionsFatigueHIV Positive+3 more
National Institute of Allergy and Infectious Diseases (NIAID) 82
Post-approval studies (Phase 4)Study completedNCT00192660
What this trial is testing

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Who this might be right for
HIV-Associated Lipodystrophy SyndromeCardiovascular Disease
Kirby Institute 80
Not applicableUnknownNCT01164605
What this trial is testing

Pilot Study of Raltegravir Lipodystrophy IISP

Who this might be right for
HIV Infection
Southern California Institute for Research and Education 30
Not applicableStudy completedNCT01098045
What this trial is testing

HIV Fat Redistribution and the Evaluation of Brown Fat

Who this might be right for
HIV Infections
Massachusetts General Hospital 27
Not applicableStudy completedNCT02530827
What this trial is testing

Energy Expenditure of People Living With HIV/AIDS

Who this might be right for
HIV/AIDSHIV Lipodystrophy Syndrome
University of Sao Paulo General Hospital 45
Testing effectiveness (Phase 2)Study completedNCT00333684
What this trial is testing

Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid

Who this might be right for
Human Immunodeficiency VirusFacial Lipoatrophy
Canadian Immunodeficiency Research Collaborative 36
Large-scale testing (Phase 3)Study completedNCT00123253
What this trial is testing

TH9507 in Patients With HIV-Associated Lipodystrophy

Who this might be right for
HIV InfectionsLipodystrophy
Theratechnologies 412
Not applicableStudy completedNCT01159743
What this trial is testing

A Comparison of Body Fat Distribution in HIV-1 Infected Patients Receiving, Since the Beginning and for at Least Two Years, an Antiretroviral Therapy Based on Efavirenz or Lopinavir/Ritonavir Combined With Tenofovir + Emtricitabine or Lamivudine

Who this might be right for
HIV Infection
AbbVie (prior sponsor, Abbott) 346
Post-approval studies (Phase 4)Study completedNCT00192621
What this trial is testing

Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects

Who this might be right for
HIV InfectionsDyslipidemiasGlucose Metabolism Disorders+3 more
Kirby Institute 50
Not applicableStudy completedNCT00149097
What this trial is testing

Role of the Autonomic Nervous System in HIV-Lipodystrophy

Who this might be right for
HIV InfectionsLipodystrophy-Syndrome
Hannover Medical School 54
Not applicableWithdrawnNCT01788462
What this trial is testing

Egrifta Replacement and Sleep Disordered Breathing

Who this might be right for
Lipodystrophy
Johns Hopkins University
Load More Results